Vitreous management during secondary implantation.
D002217:Carbachol / Q000627:therapeutic use; D006801:Humans; D006820:Hyaluronic Acid / Q000627:therapeutic use*; D007910:Lenses, Intraocular / Q000295:instrumentation / Q000379:methods*; D014822:Vitreous Body / Q000601:surgery*
D002217:Carbachol; D006820:Hyaluronic Acid